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Marfan syndrome: The variability and 
outcome of operative management 
Joseph S. Coselli, MD, Scott A. LeMaire, MD, and Suat Biiket, MD, Houston, Texas 
Purpose: This study reviews the contemporary surgical outcome of 69 patients with Marfan 
syndrome who underwent one or more aortic operations between July 18, 1989, and April 
14, 1994. 
Methods: During this 5-year period, 79 operations were performed including composite 
valve graft replacement (n = 28) and graft replacement of the thoracoabdominal aorta 
(n = 29). Fifty-seven additional operations had been performed before referral, for a total 
of 136 aortic operations in this group. Forty-two patients (60.9%) required multiple 
operations; 16 patients (23.2%) underwent three or more procedures. 
Results: Follow-up was complete on all patients. The 30-day and long-term survival rates 
were 98.7% and 96.2%, respectively. Distal aortic replacement resulted in paraparesis in
only one (2.6%) of 38 patients; no patient had development of paraplegia. No patient had 
a stroke after the use of profound hypothermic circulatory arrest. 
Conclusion: Aortic surgery prolongs survival in patients with Marfan syndrome and 
currently has low associated morbidity and mortality rates. Treatment often requires 
multiple staged operations. The variety and multiplicity of aortic manifestations i  these 
patients demonstrate the necessity for lifelong cardiovascular surveillance todetect new or 
recurrent disease. (J VAsc SURG 1995;21:432-43.) 
Marfan syndrome (MFS), a connective tissue 
disorder characterized by ocular, skeletal, and cardio- 
vascular manifestations, has an incidence of approxi- 
mately one in 20,000.~ Although usually inherited in 
an autosomal dominant pattern, MFS may also result 
from spontaneous mutation. Cardiovascular compli- 
cations, which occur in more than 95% of adults with 
MFS, are primarily responsible for the reduced life 
expectancy associated with this disorder. 2 Before the 
availability of surgical treatment, he average age of 
death in these patients was 32 years; cardiovascular 
complications were the cause of death in 93% of 
cases.3 
Recent collaborative fforts have identified ab- 
normalities involving fibrillin, a large glycoprotein 
secreted by human fibroblasts and smooth muscle 
cells, as the cause of MFS. 4-1° Fibrillin is a major 
structural component of microfibrils, which are 
present in most connective tissues and are especially 
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abundant in the elastic lamellae of the aortic wall. 
Abnormalities involving microfibrillar structure, as- 
sembly, or function may cause the aortic medial 
degenerative diseasc that is ubiquitous in MFS. 7 The 
gene coding for fibrillin has been localized to 
chromosome 15. 5,1° This new knowledge may ulti- 
mately provide a molecular basis for the diagnosis, 
prevention, and treatment of MFS. Until such time, 
however, surgical intervention will remain the main- 
stay of treatment for the associated cardiovascular 
manifestations and their inevitable life-threatening 
complications. 
Reports in the past have demonstrated 30-day, 
5-year, and 10-year survival rates of 94%, 75%, and 
56%, respectively, after aortic surgery in patients 
with MFS. n The incidence of postoperative para- 
paresis and paraplegia in patients with MFS after 
resection and graft replacement of distal aortic 
segments has been 4% for the descending thoracic 
aorta and 20% for the thoracoabdominal aorta, n,12 
Proximal aortic surgery performed with profound 
hypothermic circulatory arrest in these patients has 
carried a i0.3% early mortality rate and a 5.7% risk 
of stroke) 3With improvements in surgical care, the 
incidence of perioperative mortality and morbidity 
should decline. To evaluate the current outcome of 
surgical intervention, we retrospectively reviewed 
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Table I. Patient age at time of our initial 
surgical intervention according to decade 
No. of patients 
Age (yr) (n = 69) 
Table III. Extent of thoracoabdominal 
aortic aneurysm in patients with MFS, based 
on the Crawford classification is 
Type of TAAA No. of patients 
0-19 1 Type I 6 
20-29 15 Type II 13 
30-39 26 Type III 2 
40-49 16 Type IV 8 
50-59 7 Total 29 
60-69 4 
Table II. Aortic dissection in patients 
with MFS 
No. of 
Type of aortic dissection patients 
Acute aortic dissection 
DeBakey type I 2 
DeBakey type II i 
DeBakey type III 1 
Chronic acute dissection 
DeBakey type I 33 
DeBakey type II 1 
DeBakey type III 13 
Total 51 
our recent experience with aortic surgery in patients 
with MFS. 
PATIENTS AND METHODS 
SLxty-nine patients with MFS underwent 79 
aortic operations by the senior author (J. S.C.) during 
the period between July 18, 1989, and April 14, 
1994. The patients' ages ranged from 16 to 66 years; 
mean age was 39.4 years (Table I). In addition to the 
cardiovascular manifestations, skeletal involvement 
was identified in all 69 patients, and ocular abnor- 
malities consistent with MFS were present in 48 
patients (69.6%). 14 A definitive family history of 
MFS was confirmed in 43 patients (62.3%). 
The majority of patients (n = 47; 68.1%) had 
chronic aortic dissections (Table II). Thoracoab- 
dominal aortic aneurysms (TAAAs) were present in 
29 patients (42%), most commonly involving the 
entire descending thoracic and abdominal segments 
(i.e., Crawford type II) (Table III).15 Fifteen patients 
were admitted with annuloaortic ectasia and aortic 
insufficiency (21.7%), and one patient had coarcta- 
tion of the aorta. In addition to their aortic disease, 
two patients had bilateral common iliac artery 
aneurysms, and one patient had a left subclavian 
artery aneurysm. 
Forty (58%) patients had aortic surgery per- 
formed elsewhere before referral (Table IV). Twenty- 
seven patients (39.1%) had undergone one previous 
aortic operation, 10 patients ( 14.5 %) had undergone 
two, two patients (2.9%) had undergone three, and 
one patient (1.4%) had undergone four operations. 
Of 57 total previous operations, 40 (70.2%) were for 
ascending aortic aneurysm or aortic valve replace- 
ment (AVK). One patient had undergone prior 
mitral valve replacement (MVR) for prolapse with 
insufficiency. 
Our indications for composite valve graft (CVG) 
replacement of the ascending aorta included proximal 
aortic dissections (DeBakey types I and II) and 
annuloaortic ectasia with aortic valvular insufficiency. 
The indications for surgical repair of aortic aneu- 
rysms or distal aortic dissection (DeBakey type III) 
included symptoms uggestive of impending rup- 
ture, ischemic omplications related to dissection, or 
an aortic diameter of at least 5.5 cm as determined by 
computed tomography or magnetic resonance imag- 
ing. Infrarenal abdominal aortic aneurysms (AAAs) 
that were either symptomatic or at least 5 cm in 
diameter were replaced by use of standard techniques 
(Fig. 1). 
To date, the 69 patients in this series have under- 
gone a total of 136 aortic operations for an average of 
1.97 operations per patient (Table IV). Forty-two 
patients (60.9%) have required multiple aortic opera- 
tions, with 16 (23.2%) undergoing three or more 
such procedures thus far (Table V). 
The operations performed after referral included 
resection and graft replacement of TAAAs in 28 cases 
(40.6%) (Fig. 2), ascending aortic replacement with 
CVGs in 17 (24.6%), CVG plus transverse aortic 
arch replacement in four (5.8%), ascending aortic 
and transverse aortic arch replacement in two, 
descending thoracic aortic aneurysm replacement in 
nine (13.0%), ascending aortic false aneurysm repair 
in three, redo CVG replacement in three, infrarenal 
AAA replacement in two, and separate descending 
thoracic and TAAA replacement in one. One patient 
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Fig. 1. A, Preoperative drawing and CT scan of patient with symptomatic AAA; patient had 
undergone prior TAAA replacement. B, Postoperative drawing and aortogram after AAA 
replacement. 
Table  IV.  Previous and current aortic operations in 69 patients with MFS 
Operation performed Before referral Current (dissection) + Current (nondissection) ~ Total 
AVR 1 
Ascending aortic graft (without AVR) 8 
Ascending aortic CVG 27 
Redo ascending aortic CVG 
Repair of ascending CVG false aneurysm 1 
Ascending (without AVR) and arch graft 1 
Ascending CVG and arch graft 1 
Ascending and arch graft/noncomposite AVR 2 
Transverse aortic arch graft 3 
Coarctation repair 
Descending thoracic aortic g aft 9 
Descending and thoracoabdominal grafts 
Thoracoabdominal graft 3 
Abdominal aortic graft 1 
Total 57 
- - 1 
- -  - -  8 
5 14 46 
- 3 3 
- 4 5 
4 - 5 
6 - 7 
- -  - -  2 
1 - 4 
- 1 1 
8 1 18 
1 - 1 
25 3 31 
2 _!1 4 
52 27 136 
~Current operations denote those performed by the senior author (LS.C.). 
undergoing descending thoracic aortic replacement 
required concomitant ligation o f  an aneurysmal left 
subclavian artery, fol lowed by left carot id-to-subcla-  
vian artery bypass 8 days later. Two patients under- 
went resection and graft replacement of  bilateral iliac 
artery aneurysms during their operations for TAAA 
repair. 
Ten patients were later treated with an additional 
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Fig. 2. A, Preoperative drawing and aortogram of p tient with TAAA (Crawford, type I) 
caused by chronic DeBakey type III dissection; patient had previous CVG replacement. 
B, Postoperative drawing and aortogram after TAAA repair with attachment of multiple 
intercostal rteries. 
aortic operation at our institution. One patient with 
a CVG underwent coarctation repair 2 months after 
the initial operation. A patient underwent AAA 
replacement 11 months after repair of a CVG false 
aneurysm, completing total aortic replacement. 
Three months after a redo descending thoracic aortic 
graft replacement for treatment of a false aneurysm, 
a patient underwent primary repair of a false aneu- 
rysm arising from the anulus of a previously placed 
CVG. Three weeks after graft replacement of the 
descending thoracic aorta in a patient with a chronic 
DeBakey type I dissection, replacement of the 
transverse aortic arch and replacement of a preexist- 
ing ascending graft with a new CVG was performed, 
completing total aortic replacement. In the remain- 
ing six patients, the original operation was TAAA 
replacement. The subsequent operation in these 
patients included CVG replacement of the ascending 
Table V. Number of aortic operations 
per patient 
No. of aortic operations 
per patient No. of patients 
1 27 
2 26 
3 9 
4 5 
5 2 
aorta in two (2 months and 3 months after the initial 
operation), replacement of the transverse aortic arch 
in one (12 months later), CVG insertion plus 
transverse arch replacement i  one (8 months later), 
and replacement of the distal ascending and trans- 
verse arch in two patients (3 months and 13 months 
later). Both of the latter two patients had tmdergone 
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Fig. 3. A, Preoperative drawing and aortogram of patient with false aneurysm arising from 
site of right coronary artery reattachment on previously placed CVG (Bentall operation). 
B, Drawing and CT scan. C, Postoperative drawing and aortogram after repair, with Dacron 
graft to right coronary origin, and additional distal aortic graft inserted. 
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prior CVG insertion and consequently had staged 
total aortic replacement. These subsequent opera- 
tions constituted the second aortic operation in two 
patients, the third operation in three patients, the 
fourth in four patients, and the fifth in one patient. 
Surgical treatment of complications from previ- 
ous aortic surgery was necessary in nine patients 
(13.0%). One patient was treated for a false aneu- 
rysm involving a thoracoabdominal aortic graft, and 
another required treatment for a false aneurysm 
arising from a descending thoracic aortic graft. Each 
of the other seven patients had complications result- 
ing from prior CVG insertion. Three of these had 
noninfected false aneurysms arising from the right 
coronary artery reattachment site on CVGs placed by 
use of the Bentall technique. 16Two of these pseudo- 
aneurysms were treated by primary suture line repair; 
the other required Dacron graft interposition to the 
right coronary artery (Fig. 3). Another patient with 
prior Bentall CVG insertion had a large noninfected 
false aneurysm arising from the aortic anulus. After 
evacuation of the hematoma and suture line repair of 
the pseudoaneurysm, an omental pedicle was used to 
fill the dead space left by the resected false aneurysm. 
The remaining three patients had infected false 
aneurysms arising from the aortic anulus of their 
CVGs-two of which had been inserted by the 
BentaU method and one placed via the Cabrol 
procedure. 17Each required resection of all foreign 
material, wide debridement, and CVG rereplacement 
for treatment of endocarditis, valve dehiscence, and 
false aneurysm. A viable pedicle of omentum was 
used in all three cases to cover the new grafts and fill 
surrounding dead space, z8,19 
The techniques for operations on the ascending, 
transverse arch, descending thoracic, and thoracoab- 
dominal segments of the aorta have been previously 
described in detail. 5,2°25 CVG replacement was 
performed in all patients undergoing operation on 
the aortic valve and ascending aorta. In the patients 
with ascending aortic aneurysms without dissection, 
CVG replacement was performed uring moderate 
hypothermia nd cardiopulmonary b pass. In all 
patients with acute DeBakey type I aortic dissections, 
however, the operation was carried out with pro- 
found hypothermic circulatory arrest, thereby avoid- 
ing cross-clamp injury of the intimal flap. After 
examination of the arch for additional tears that 
may have needed repair or excision, the false lumen 
was obliterated in the distal suture line. Sixteen of 
the 28 patients requiring insertion of CVGs had 
not undergone prior heart surgery. The button 
technique for reattachment of the coronary arteries 
(Fig. 4) was used in 15 of these patients, and the 
Cabrol operation was performed in one. Of the 12 
patients who had undergone prior heart surgery, the 
Cabrol method was used in 11 and the button 
technique was used in one. 
Replacement of the transverse aortic arch was 
performed along with CVG replacement in five 
patients with chronic DeBakey type I dissections and 
in one patient with an acute DeBakey type II 
dissection superimposed ona preexisting arch aneu- 
rysm. Graft replacement of the transverse aortic arch 
for either fusiform aneurysm or dissection also 
necessitated the use of circulatory arrest. Reversed 
cerebral perfusion via the superior vena cava was used 
as an adjunct for brain protection in five cases 
requiring circulatory arrest. 
Resection and graft replacement of either the de- 
scending thoracic or thoracoabdominal aortic seg- 
ment included the reattachment of intercostal ar- 
teries; the latter operation also involved reattachment 
of the visceral arteries (Fig. 5). Twenty-one (55.3%) 
of the 38 patients who underwent resection and graft 
replacement of the descending thoracic aorta (n = 8) 
or thoracoabdominal aorta (n = 13) did not require 
the use of cardiofemoral bypass. In 16 patients 
(42.1%) undergoing replacement of distal aortic seg- 
ments (descending thoracic aorta in one, thoracoab- 
dominal aorta in 14, and both segments in one pa- 
tient), cardiofemoral bypass with an in-line BioMedi- 
cus centrifugal pump was used to provide distal 
perfusion to the visceral vessels and intercostal rter- 
ies during the period of proximal anastomosis. All 
patients in whom cardiofemoral bypass was used had 
chronic aortic dissection except one patient who un- 
derwent an emergency descending thoracic aortic re- 
placement for an acute DeBakey type III dissection. 
One of the patients with dissection underwent sepa- 
rate graft replacement of the descending thoracic 
aorta and the thoracoabdominal aorta from the dia- 
phragm to the bifurcation (type IV) during the same 
operation (Fig. 6). Finally, one patient with a TAAA 
required femorofemoral bypass and profound hypo- 
thermic irculatory arrest, because aortic size at the 
distal arch (12 cm) did not allow placement of a 
clamp for proximal control. In no case was cere- 
bral spinal fluid drainage or intrathecal papaverine 
used.  27 
Two patients required MVR; one had previously 
undergone a porcine MVR and underwent rereplace- 
ment with a mechanical valve at the time of ascending 
CVG insertion, and the other patient required 
emergency MVR for acute rupture of the chordae 
papillary complex after CVG placement. Both pa- 
JOURNAL OF VASCULAR SURGERY 
438 Coselli, LeMaire, and Biiket March 1995 
Fig. 4. A, Preoperative aortogram and drawing of patient with annuloaorfic ectasia. B, 
Postoperative drawing and aortogram after CVG insertion with direct reattachment of coronary 
ostia via button technique. 
tients underwent MVR via the standard left atri- 
otomy. 
RESULTS 
Follow-up was complete on all 69 patients. There 
was one in-hospital death for a 30-day survival rate of 
98.7% and two late deaths for a long-term survival 
rate of 96.2%. 
The patient who died in-hospital had undergone 
two previous aortic operations elsewhere-CVG 
replacement of the ascending aorta for an acute 
DeBakey type I dissection, and subsequent primary 
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Fig. 5. A, Preoperative aortogram and drawing of patient with extensive TAAA (Crawford 
type II) caused by chronic DeBakey type III dissection. B, Postoperative aortogram and draw- 
ing of patient after TAAA replacement. 
repair of an annular dehiscence and pseudoaneurysm. 
The postoperative course wascomplicated by sternal 
wound infection, bacterial endocarditis, troke, and 
congestive heart failure. After referral for treatment 
of recurrent pseudoaneurysm and dehiscence of the 
aortic valve annulus, resection and rereplacement of 
the entire CVG was performed, with placement of a 
viable omental pedicle into the mediastinum for 
coverage of the aortic graft and filling of the dead 
space. Two weeks after the operation, the patient died 
suddenly as a result of a cardiac dysrrhythmia. 
Two late deaths occurred 6 months and 3 years 
after operation. The causes of late death were 
respiratory insufficiency in one patient and compli- 
cations from acquired immune deficiency syndrome 
in the other. The patient who died of acquired 
immune deficiency syndrome had positive findings 
for human immunodeficiency virus at the time of 
surgery, which was carried out for annuloaortic 
ectasia with severe aortic valvular insufficiency and 
secondary congestive heart failure. 
Of the 38 distal aortic replacement operations 
performed, only one (2.6%) resulted in a postoper- 
ative lower extremity neurologic deficit of moderate 
degree (paraparesis). There were no cases of postop- 
erative paraplegia. The patient who had development 
of paraparesis was a 63-year.-old woman who was 
admitted with hypotension and a ruptured type II 
TAAA. The patient underwent emergency replace- 
ment of the aorta from the left subclavian artery to 
below the renal arteries, with insertion of a separate 
graft to the left renal artery, without the use of 
cardiofemoral bypass. Interestingly, the aneurysm 
had ruptured just above the diaphragm into a very 
large hiatal hernia sac and was consequently partially 
contained. 
No patient had a postoperative stroke after the 
use of profound hypothermic circulatory arrest. 
DISCUSSION 
Surgical correction of life-threatening cardiovas- 
cular manifestations can bc performed with excellent 
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Fig. 6. A, Preoperative drawing and aortogram f p tient with chronic DeBakey type III 
dissection and aneurysms of descending and thoracoabdominal aorta (Crawford type IV). B, 
Postoperative drawing and aortogram after sep rate placement of descending aorta and 
thoracoabdominal aorta. 
survival rates. With improvements in operative tech- 
niques, anesthetic are, and perioperative manage- 
ment, the incidence of major complications after 
these aortic procedures has declined in recent years, 
resulting in the very low associated morbidity rate 
demonstrated in this series. 
Paraplegia remains one of the most devasta- 
ting complications after resection and graft replace- 
ment of the descending thoracic or thoracoabdomi- 
nal aorta. 12,27,28 Replacement of distal aortic seg- 
ments performed in patients with MFS at our 
institution between the years of 1966 and 1988 
resulted in paraplegia or paraparesis n 4% of those 
who underwent descending thoracic aortic replace- 
ment and 22% of those who underwent TAAA 
repair. 11 Our current series demonstrates that re- 
finements in technique have substantially reduced 
the incidence of this complication. In this series a 
very aggressive approach was applied to the reat- 
tachment of intercostal arteries, and distal aortic 
perfusion was used selectively in patients with 
extensive TAAAs (Crawford type I or II), particu- 
larly in those with dissection. The low number of 
neurologic complications prohibited statistical 
evaluation of the influence of distal perfusion tech- 
niques on outcome. 
Diffuse dilation of the proximal segment of the 
ascending aorta with aortic annular dilation and 
secondary aortic valvular insufficiency is the most 
common cardiovascular manifestation i  MFS. Sepa- 
rate replacement of the aortic valve and ascending 
aorta results in aneurysmal dilation f the sinus 
segment in all cases. 2s The single most important 
contribution to the treatment of patients with aortic 
root aneurysms was by Bentall and DeBono, ~6 who 
reported the first successful CVG replacement with 
direct reattachment of the coronary artery origins to 
openings in the graft. 29 In this procedure the aortic 
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Fig. 7. A, Preoperative aortogram and drawing of patient with annuloaortic ectasia, aortic 
valvular insufficiency, and superimposed chronic DeBakey type II dissection. B, Drawing 
and CT scan of aneurysm with 12 cm diameter. C, Postoperative drawing a daortogram after 
CVG insertion with use of Cabrol technique. 
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aneurysm wall was wrapped around the composite 
graft for purposes of hemostasis. 
Unfortunately, tension at the coronary anasto- 
moses and lack of access to the suture lines are 
frequently the causes of intraoperative bleeding and 
postoperative pseudoaneurysm formation after the 
Bentall operation.l~,21 Anastomotic problems involv- 
ing Bentall CVGs were the most common compli- 
cation requiring reoperation i our series. Of the 28 
patients who had prior CVG replacement, 25% 
(n = 7) had development of secondary complica- 
tions requiring reoperation; six of these seven CVGs 
were inserted by use of the Bentall technique. 
In their reported experience with. 127 patients 
requiring CVG insertion, Kouchoukos et al.30 per- 
formed the classic Bentall technique with aortic wall 
wrap in the initial 103 patients; 24 subsequent pa- 
tients underwent CVG insertion with the button 
technique for reattachment of the coronary artery 
origins. This latter technique resulted in a markedly 
reduced incidence of intraoperative hemorrhage 
and postoperative false aneurysm formation. 3°De- 
pending on the distance between the anulus and coro- 
nary ostia, Gott et al.29 currently use either the button 
technique or a "no-wrap" modification of the Bentall 
technique, with excellent results. As a method of re- 
lieving anastomotic tension, Cabrol et al)7 suggested 
interposing a transversely positioned Dacron tube 
graft between the aortic graft and the aortic tissue 
surrounding the coronary artery origins. 
We use CVG replacement in all patients with 
MFS undergoing operation on the aortic valve or 
ascending aorta. 2°,21 In light of the above complica- 
tions, we preferentially use the button technique 
whenever possible in all patients undergoing first- 
time operations, allowing direct, tension-free re- 
attachment of the coronary artery origins to the aortic 
graft. 2° In patients undergoing redo operations and 
in selected patients with dissection or enormous 
aneurysms-making mobilization of the proximal 
coronary arteries impractical or impossible-the 
Cabrol operation or a similar modification is used 
(Fig. 7).26 In a previous eries we have reported 97% 
and 100% 3-year freedom from reoperation after the 
Cabrol and button techniques, respectively. Like- 
wise, of the 28 patients in this current series who 
underwent CVG replacement a  our institution (16 
via button technique and 12 via Cabrol method), no 
patient has required reoperation for complications. 
Patients with MFS and TAAA tend to have an 
increased incidence of aortic dissection and aneu- 
rysms of more extensive involvement (Crawford type 
I and II). 2s Eighteen percent of all patients with 
TAAAs (with and without MFS) have concomitant 
celiac, superior mesenteric, or renal artery occlusive 
disease. 31 The overall younger age of patients with 
MFS results in a lower incidence of visceral occlusive 
disease from superimposed atherosclerosis, but this is 
somewhat offset by impairment from dissection. In 
the reattachment of visceral vessels to the aortic graft 
in TAAA repair, it is improtant to exclude as much 
aortic wall as is feasible by placing the suture line at 
the margin of the arterial orifice and reattaching 
arteries arising from the false lumen to a separate 
opening in the aortic graft from those arising from 
the true lumen. In the case of TAAAs resulting from 
chronic dissection, the visceral vessels may arise from 
the patent false lumen; to prevent ischemic ompli- 
cations after TAAA repair, the distal anastomosis 
must direct blood flow into both true and false 
channels when carried out proximal to the celiac axis. 
The ability to prolong survival in patients with 
MFS through aortic operations with low associated 
mortality and morbidity rates, as demonstrated 
above, supports an aggressive surgical approach to 
these lesions. All symptomatic aneurysms, ofcourse, 
require urgent operation. CVG replacement of the 
ascending aorta is indicated for all patients with 
proximal aortic dissection or significant aortic valvu- 
lar insufficiency. In the absence of these problems, 
patients with MFS who have asymptomatic horacic 
or thoracoabdominal aneurysms hould undergo 
elective resection and graft replacement when the 
aortic diameter exceeds 5.5 cm. For infrarenal AAAs, 
this threshold is lowered to 5 cm. 
Mitral valve dysfunction occurs in up to 80% of 
patients with MFS; however, only 14% of patients 
with MFS have development of mitral valve disease 
severe nough to warrant operation.32 Indications for 
surgery include hemodynamic deterioration and the 
development of dysrhythmias. Surgical options in- 
clude MVR, valve repair, and ring annuloplasty. 
Only two patients in our series required MVR; both 
procedures were performed via a standard left atri- 
otomy, although a transaortic approach is also 
possible. 33 
The variety and multiplicity of aortic operations 
in this series demonstrate the frequent need for 
multiple aortic operations and confirm the necessity 
for lifelong cardiovascular surveillance in patients 
with MFS. In the series reported by Svensson et al.l~, 
untreated valvular disease, aneurysms, and pseudo- 
aneurysms caused 39.3% (11/28) of the late deaths 
after aortic surgery in patients with MFS; therefore 
new lesions must be searched for and treated 
aggressively. Both of the remaining segments of 
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unreplaced aorta and previously repaired segments 
must be carefully monitored to detect he develop- 
ment of additional aneurysms, recurrent dissection, 
or anastomotic complications. All patients with MFS 
who have undergone surgery should therefore un- 
dergo routine imaging of the aorta by means of 
computed tomography ormagnetic resonance imag- 
ing 6 months after surgery and annually thereafter. In
all patients with MFS and without CVGs, the aortic 
root and valve need to be evaluated with annual 
echocardiography and Doppler flow analysis. 
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